By M. Narkam. New York University. 2019.
Loss of function is im- amovement cheap 100mg eriacta amex std that causes erectile dysfunction, such as extension at the knee caused by a portant as therapy aims to both relieve pain and establish mechanical block such as a foreign body in the joint or necessary function for daily activities discount eriacta uk erectile dysfunction protocol amazon. Seropositivity allows prediction of severity and the need for earlier aggressive therapy and Although some of the available tests used in diagnosis increases the likelihood of extra-articular features generic eriacta 100mg on-line erectile dysfunction in young. Combin- ing tests may allow a clinical diagnosis to be conmed Joint aspiration (see Table 8. Rheumatoid factor: These are antibodies of any class Unexplained joint swelling may require aspiration to directed against the Fc portion of immunoglobulins. The aspiration itself may be of therapeu- The routine laboratory test detects only IgM antibodies, tic value lowering the pressure and relieving pain. It is which agglutinate latex particles or red cells opsonised often coupled with intra-articular washout or instilla- with IgG. It is the presence of these IgM rheumatoid tion of steroid or antibiotic as appropriate. Examina- factor antibodies that is used to describe a patient as tion of the synovial uid may be of diagnostic value (see seropositive or seronegative. Local spread from a soft tissue infection atively birefringent, whereas the crystals of pseudogout may also occur. Previously Haemophilus inuenzae was seen in young children, Many modalities of joint imaging and direct visualisa- but it is now rare due to vaccination. Patients with tion are used to diagnose and follow the course of mus- sickle cell anaemia are prone to osteomyelitis due to culoskeletaldisordersandareoftenusedincombination. The ndings in individual conditions will be described r Direct spread from local infection may occur with later. Streptococcus, Staphylococcus, anaerobes and gram- r X-ray: Many musculoskeletal disorders have charac- negative organisms. Pathophysiology Comparison of X-ray changes over time is especially In children the long bones are most often involved; in useful in monitoring disorders that have a degenera- adults, vertebral, sternoclavicular and sacroiliac bones tive course. In- r Ulrasound is of value in examining the joint and sur- fections from a distant focus spread via the blood stream rounding soft tissue. In children the organisms usually diagnosing the cause of a painful hip not amenable to settle in the metaphysis because the growth disc (physis) palpation. Acute inammation occurs accompanied by a rise in It can demonstrate both bone and soft tissue disor- pressure leading to pain and disruption of blood ow. In children infectious conditions prior to X-ray changes, it is of the physis acts as a physical barrier to intra-articular great value in identifying malignant bone inltration spread. Bone and joint infections Clinical features Presentationrangesfromanacuteillnesswithpain,fever, swelling and acute tenderness over the affected bone, to Acute osteomyelitis an insidious onset of non-specic dull aching and vague Denition systemic illness. Complications Age r As thebonehealsandnewboneisformed,infectedtis- Normally seen in children and adults over 50 years. Aetiology Investigations Previously, chronic osteomyelitis resulted from poorly r The X-ray nding may take 2 3 weeks to develop. It now occurs more fre- raised periostium is an early sign that may be seen quentlyinpost-traumaticosteomyelitis. With healing there is sclerosis and seques- Pathophysiology trated bone fragments may be visible. Blood cultures are positive in the bone may remain dormant for years giving rise to 50%. Clinical features The clinical course is typically ongoing chronic pain Management r and low-grade fever following an episode of acute os- Surgical drainage should be used if there is a subpe- teomyelitis. There may be pus discharging through a si- riosteal abscess, if systemic upset is refractory to an- nus. However, if the pus is retained within the bone or tibiotic treatment or if there is suspected adjacent join the sinus becomes obstructed, rising pressure leads to an involvement. Par- enteral treatment is often required for a prolonged period (2 4 weeks) prior to a long course of oral an- Investigations tibiotics to ensure eradication. Theperiostiummayberaisedwithunderlying with a third-generation cephalosporin to cover for new bone formation. Management r Adequate analgesia is essential and may be improved Discharging sinuses require dressing, and if an abscess with splints to immobilise the limb (which also helps persists despite antibiotic therapy it should be incised to avoid contractures). Prolonged combined parenteral antibiotics to reduce associated muscle disuse atrophy and to are required. In early stages the joint space is preserved, but later there is narrowing and ir- Tuberculous bone infection regularity with bone erosion and calcication within adjacent soft tissue. Incidence Patients with tuberculosis have a 5% lifetime risk of Management developing bone disease. Chemotherapy with combination anti-tuberculous agents for 12 18 months (see page 105). Rest and trac- tion may be useful; if the articular surfaces are damaged, Age arthrodesis or joint replacement may be required. Geography Septic arthritis Major illness in developing countries, with increasing Denition incidence in the developed world. Aetiology Tuberculous osteomyelitis is usually due to haematoge- Aetiology nous spread from a primary focus in the lungs or gas- Joint infection arises most commonly from haematoge- trointestinal tract (see pages 105 and 154). Other mechanisms include local trauma or creased the incidence of tuberculosis and tuberculous an adjacent infective focus such as osteomyelitis. The patient complains of pain and later swelling due to Pathophysiology pus collection. Muscle spasm and wasting occur with Bacteriaareinitiallyfoundinthesynovialmembranebut limitation of movement and rigidity. Cytokine-mediated losis, pain may be mild and presentation delayed until inammationandariseinintra-articularpressurefollow thereisavisibleabscessorvertebralcollapsecausingpain the spread of bacteria. Erosion of the articular cartilage results from the In previously healthy children and adults, penicillin release of proteolytic enzymes from neutrophils within (Streptococcus cover) and ucloxacillin (Staphylococ- the inammatory exudate. A third-generation cephalosporin enzymes can result in chondrocyte and bone damage. If the hip The classical features of septic arthritis are a red, hot, is infected it should be held abducted and 30 exed. Overall the Drainage of pus and arthroscopic joint washout under knee is the most commonly affected joint, but hips are anaesthesia can be performed. There may be evidence of the r Surgical drainage may be indicated if the infection source of infection such as a urinary tract infection, skin does not resolve with appropriate antibiotics or if per- orrespiratoryinfection. Arthroscopic pro- immobilised in the position that maximises the intra- cedures allow visualisation of the interior of the joint, articular volume (e. Movement of the joint r Surgerymayalsoberequiredfortheremovalofforeign is very painful and often prevented by pain and muscle bodies or infected prosthetic material. Complications r If treatmentisdelayedthereisseverearticulardestruc- Prognosis tion, which may heal by brosis with permanent re- Outcome is related to immune status of the host, viru- striction of movement, deformity or bony union. In Staphylococcal infections r In children extensive destruction of the epiphysis may involvement of multiple joints carries a signicant mor- occur causing growth disturbance and deformity.
Economic policies of developing countries may not allow large investments in health care buy eriacta 100 mg amex impotence nitric oxide, hospitals purchase 100 mg eriacta overnight delivery herbal erectile dysfunction pills review, brain scanners or rehabilitation facilities cheap eriacta 100 mg with amex erectile dysfunction shot treatment. Health care in the acute phase of stroke is the most costly component of the care of stroke patients; in low-resource countries hospital care of even a small proportion of all patients with stroke accounts for a disproportionately high share of total hospital costs. Stroke units, which have been shown to reduce mortality, morbidity and other unfavourable outcomes without necessarily increasing health costs, are available in very few developing countries. Costs of consultation, investigation, hospitalization and medication may be beyond the means of poor people, especially those who do not have welfare benets or medical insurance plans. This seriously hampers the provision of care to patients who are otherwise able to seek medical attention. Although hospital care represents a large proportion of the costs of stroke, institutional care also contributes signicantly to overall stroke care costs. Most developing countries do not have well-established facilities for institutional care. The bulk of long-term care of the stroke patient is likely to fall on community services and on family members, who are often ill equipped to handle such issues. There is thus a need for appropriate resource planning and resource allocation to help families cope with a stroke-impaired survivor. Priorities for stroke care in the developing world Governments and health planners in developing countries tend to underestimate the importance of stroke. To compound this difculty, 80% of the population in developing countries live in rural areas, a factor that limits access to specialized services. To achieve this task, stroke prevention awareness must be neurological disorders: a public health approach 161 raised among health-care planners and governments. Another priority is education of the general public and health-care providers about the preventable nature of stroke, as well as about warning symptoms of the disease and the need for a rapid response. Furthermore, allocation of resources for implementation and delivery of stroke services (e. Finally, it is very important to establish key national institutions and organizations that would promote training and education of health professionals and dissemination of stroke- relevant information. The primary focus of this international collaboration will be to harness the necessary resources for implementing existing knowledge and strategies, especially in the middle and low income countries. The purpose of this strategy is threefold: to increase awareness of stroke; to generate surveillance data on stroke; and to use such data to guide improved strategies for prevention and management of stroke (20). The Global Stroke Initiative is only possible through a strong interaction between governments, national health au- thorities and society, including two major international nongovernmental organizations. Increasing awareness and advocacy among policy-makers, health-care providers and the general public of the effect of stroke on society, health-care systems, individuals and families is fundamental to improving stroke prevention and management. Advocacy and awareness are also essential for the development of sustainable and effective responses at local, district and national levels. Policy-makers need to be informed of the major public health and economic threats posed by stroke as well as the availability of cost-effective approaches to both primary and secondary prevention of stroke. Health professionals require appropriate knowledge and skills for evidence-based prevention, acute care and rehabilitation of stroke. Relevant information needs to be provided to the public about the potential for modifying personal risk of strokes, the warning signs of impending strokes, and the need to seek medical advice in a timely manner. One of the major prob- lems of stroke epidemiology is the lack of good-quality epidemiological studies in developing countries, where most strokes occur and resources are limited. This exible and sustainable system includes three steps: standard data acquisition (recording of hospital admission rates for stroke), expanded population coverage (calculation of mortality rates by the use of death certi- cates or verbal autopsy), and comprehensive population-based studies (reports of nonfatal events to calculate incidence and case-fatality). These steps could provide vital basic epidemiological estimates of the burden of stroke in many countries around the world (20). Primary prevention of ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Mortality by cause for eight regions of the world: global burden of disease study. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Prevention of recurrent heart attacks and strokes in low and middle income populations: evidence-based recommendations for policy-makers and health professionals. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Guidelines for prevention of stroke in patients with ischaemic stroke or transient ischaemic attack. Rehabilitation, prevention and management of complications, and dis- charge planning. Many years of productive life 173 Conclusions and recommendations are lost, and many people have to suffer years of disability after brain injury. In addition, it engen- ders great economic costs for individuals, families and society. The world is facing a silent epidemic of road trafc accidents in the developing countries: by 2020, road trafc crashes will have moved from ninth to third place in the world ranking of the burden of disease and will be in second place in developing countries. Systematic triage of patients can lead to important economic savings and better use of scant hospital resources. More standardized pre-hospital and in-hospital care, to minimize secondary brain injury, can improve outcomes substantially. Acceleration and deceleration forces may disrupt the nervous tissue and blood vessels of the brain. The intermediate category, moderate head injury, implies a mortality rate of 2 5%. Further classication of the brain injury is made in order to evaluate prognosis, identify pa- tients at risk for deterioration and choose appropriate observation and treatment. Someone who opens his eyes only after painful stimulation, utters only incomprehensible sounds and withdraws his hand only after pinching will be given a score of 8. A fracture detected on the skull X-ray images indicates an increased risk of deterioration, and the patient will need admission. In spite of these reservations, it can be interesting and informative to compile data from different parts of the world. Some of the differences could be as- cribed to variations in study years, inclusion criteria and research methods. Therefore, incidence rates such as 546 per 100 000 per year in Sweden and 91 per 100 000 per year in Spain must be interpreted with caution. Data from many parts of the world consistently show a peak incidence rate in children, young adults and elderly people. Information on how sequelae develop (diminish or increase) over time is scarce (8); better data on prevalence would certainly be useful for improved planning of rehabilitation needs. The average European pre-hospital case-fatality rate was 8%, while the in-hospital rate was 3%, i. Mortality rate per 100 000 population per year is more informative than the case-fatality rate.
Although one might expect a higher exposure to perinatal risk factors order eriacta 100mg fast delivery impotence from diabetes, infections and traumas in developing countries purchase generic eriacta erectile dysfunction 16 years old, the higher incidence of epilepsy may be also explained by the different structure of the populations at risk proven 100 mg eriacta erectile dysfunction treatment stents, which is characterized by a predominant distribution of young individuals and a short life expectancy. Incidence by age, sex and socioeconomic status In industrialized countries, epilepsy tends to affect mostly the individuals at the two extremes of the age spectrum. The peak in the elderly is not detected in developing countries, where the disease peaks in the 10 20-year age group (8). This may depend on the age structure of the population and on a relative under-ascertainment of the disease in older individuals. The incidence of epilepsy and unprovoked seizures has been mostly reported to be higher in men than in women in both industrialized and developing countries, though this nding has rarely attained statistical signicance. The different distribution of epilepsy in men and women can be mostly ex- plained by the differing genetic background, the different prevalence of the commonest risk factors in the two sexes, and the concealment of the disease in women for sociocultural reasons. This assumption is sup- ported by the comparison between industrialized and developing countries and by the comparison, within the same population, of people of different ethnic origin (9). The prevalence of active epilepsy is generally lower in industrialized countries than in developing countries, which may reect a lower prevalence of selected risk factors (mostly infections and traumas), a more stringent case verication, and the exclusion of provoked and unprovoked isolated seizures. Prevalence by age, sex and socioeconomic status In industrialized countries, the prevalence of epilepsy is lower in infancy and tends to increase thereafter, with the highest rate occurring in elderly people (10). Where available, age-specic prevalence rates of lifetime and active epilepsy from developing countries tend to be higher in the second (254 vs 148 per 1000) and third decades of life (94 vs 145 per 1000) (8). The differences between industrialized and developing countries may be mostly explained by the differing distribu- tion of the risk factors and by the shorter life expectancy in the latter. However, this nding is not consistent across studies and, with few exceptions, is not statistically signicant. Socioeconomic background has been found to affect the frequency of epilepsy reports in both industrialized and developing countries. In developing countries, prevalence rates have been shown to be greater in the rural compared with the urban context (11, 12 ) or in the lower compared with the higher socioeconomic classes. However, opposite gures were reported in a meta-analy- sis of epidemiological studies from India (13), which suggests that rural and urban environments should not be invariably used as proxies of lower vs higher socioeconomic conditions. Mortality The mortality rate of epilepsy ranges from 1 to 8 per 100 000 population per year, but international vital statistics give annual mortality rates of 1 2 per 100 000 (14). The highest mortality risk in the youngest age groups can be interpreted in part in the light of the underlying epileptogenic conditions and the lower number of competing causes of death. It is extremely difcult to analyse the epilepsy death rate in the general population of a devel- oping country because incidence studies of epilepsy are difcult to perform, death certicates are unreliable and often unavailable, and the cause of death is difcult to determine. Based on available data, it seems that the mortality rate of epilepsy in developing countries is generally higher than that reported in developed countries. These data cannot be generalized, however, as they have been obtained from selected populations (17 ). Many more people, however an estimated 200 000 000 are also affected by this disorder, as they are the family members and friends of those who are living with epilepsy. Up to 70% of people with epilepsy could lead normal lives if properly treated, but for an overwhelming majority of patients this is not the case (18). People with hidden disabilities such as epilepsy are among the most vulnerable in any society. While their vulnerability may be partly attributed to the disorder itself, the particular stigma associated with epilepsy brings a susceptibility of its own. Stigmatization leads to discrimination, and people with epilepsy experience prejudicial and discriminatory behaviour in many spheres of life and across many cultures (20). People with epilepsy experience violations and restrictions of both their civil and human rights. Discrimination against people with epilepsy in the workplace and in respect of access to education is not uncom- mon for many people affected by the condition. Violations of human rights are often more subtle and include social ostracism, being overlooked for promotion at work, and denial of the right to participate in many of the social activities taken for granted by others in the community. For example, ineligibility for a driving licence frequently imposes restrictions on social participation and choice of employment. Informing people with epilepsy of their rights and recourse is an essential activity. Considering the frequency of rights violations, the number of successful legal actions is very small. People are often reluctant to be brought into the public eye, so a number of cases are settled out of court. The successful defence of cases of rights abuse against people with epilepsy will serve as precedents, however, and will be helpful in countries where there are actions afoot to review and amend legislation. It is apparent that close to 90% of the worldwide burden of epilepsy is to be found in developing regions, with more than half occurring in the 39% of the global population living in countries with the highest levels of premature mortality (and lowest levels of income). An age gradient is also apparent, with the vast majority of epilepsy-related deaths and disability in childhood and adolescence occurring in developing regions, while later on in the life-course the proportion drops on account of relatively greater survival rates into older age by people living in more economically developed regions. Since such studies differ with respect to the exact methods used, as well as underlying cost structures within the health system, they are currently of most use at the level of individual countries, where they can serve to draw attention to the wide-ranging resource implications and needs of people living with epilepsy. The avertable burden of epilepsy Having established the attributable burden of epilepsy, two subsequent questions for decision- making and priority setting relate to avertable burden (the proportion of attributable burden that is averted currently or could be avoided via scaled-up use of proven efcacious treatments) and resource efciency (determination of the most cost-effective ways of reducing burden). In all nine developing regions, the cost of securing one extra healthy year of life was less than average per capita income. Extending coverage further to 80% or even 95% of the target population would evidently avert more of the burden still, and would remain an efcient strategy despite the large-scale investment in manpower, training and drug supply/distribution that would be required to implement such a programme. The goal of treatment should be the maintenance of a normal lifestyle, preferably free of seizures and with minimal side-effects of the medication. Investment in epilepsy surgery centres, even in the poorest regions, could greatly reduce the economic and human burden of epilepsy. There is a marked treatment gap with respect to epilepsy surgery, however, even in industrialized countries. Attention to the psychosocial, cognitive, educational and vocational aspects is an important part of comprehensive epilepsy care (30). Epilepsy imposes an economic burden both on the affected individual and on society, e. Over the past years, it has become increasingly obvious that severe epilepsy-related difculties can be seen in people who have become seizure free as well as in those with difcult-to-treat epilepsies. The outcome of rehabilitation programmes would be a better quality of life, improved general social functioning and better functioning in, for instance, performance at work and im- proved social contacts (31). From an economic point of view also, therefore, it is an urgent public health challenge to make effective epilepsy care available to all who need it, regardless of national and economic boundaries. Prevention Currently, epilepsy tends to be treated once the condition is established, and little is done in terms of prevention. In a number of people with epilepsy the cause for the condition is unknown; prevention of this type of epilepsy is therefore currently not possible (33, 34). A sizeable number of people with epilepsy will have known risk factors, but some of these are not currently amenable to preventive measures.
Several current studies have demonstrated the additive effects of antihistamines and antileukotriene agents in both allergic rhinitis and asthma buy generic eriacta pills drugs for erectile dysfunction list. Antihistamines serve as important adjuncts in the management of anaphylaxis but should never replace the first-line therapy order eriacta canada impotence yahoo, which by general consensus is epinephrine (10) discount generic eriacta canada erectile dysfunction treatment new orleans. Antihistamines are commonly used to treat atopic dermatitis but have limited clinical utility. The sedating first-generation antihistamines, such as diphenhydramine and hydroxyzine, are often more effective than nonsedating agents for controlling pruritus because they allow the patient to sleep. Antihistamines should be used cautiously during pregnancy to avoid the risk for teratogenicity ( 10). Long-term clinical experience using antihistamines during pregnancy has shown that tripelennamine, chlorpheniramine, and diphenhydramine cause no greater risk for birth defects than experienced by the normal population. Antihistamines are excreted in breast milk and therefore infants of nursing mothers who were taking first-generation antihistamines have been reported to experience drowsiness and irritability. Studies evaluating these agents in the treatment of children with otitis media and upper respiratory infections have found they offer no significant benefit when used as solo agents (95,96 and 97). However, children with recurrent otitis media and a strong family history of allergies should be evaluated by an allergist to identify potential environmental triggers. The use of second-generation over first-generation antagonists as first-line agents has previously been considered premature by many experts. If a first-generation agent is taken on a regular basis at bedtime, its sedative side effects are often well tolerated by many patients. However, because a large segment of patients do not tolerate these agents, they require treatment with second-generation nonsedating agents. Impairment of these functions increases indirect costs associated with the treatment of allergic rhinitis. Indirect costs include missed days from work or school and decreased concentration and performance while at work, resulting in overall decreased productivity ( 3,42). However, if individuals have nonallergic rhinitis with or without an allergic component manifested as severe postnasal drainage, it may be necessary to use first-generation antihistamines with or without decongestants to take advantage of their anticholinergic drying effects. In these situations, it is best to dose the sedating antihistamine at bedtime because the sedative carryover effect the following morning of these agents does not usually significantly impair cognitive performance. In general, it is important to educate the patient about the advantages and disadvantages of sedating and nonsedating antihistamines in the management of specific allergic diseases. Some patients become drowsy with even 2 mg of chlorpheniramine, so that second-generation antihistamines should be used instead. Associated anticholinergic side effects include dry mouth, blurred vision, and urinary retention ( 99). First-generation agents also potentiate the effects of benzodiazepines and alcohol ( 10,99). Cyproheptadine, a piperidine, has the unique effect of causing weight gain in some patients (16). Intentional and accidental overdose, although uncommon, has been reported with these drugs ( 10,14). Even with normal doses, it is not unusual for children to experience a paradoxic excitatory reaction. Malignant cardiac arrhythmias have been known to occur with overdoses, emphasizing the need to act expeditiously to counteract the toxic effect of these agents ( 10,14,99). Because these agents are secreted in breast milk, caution should be exercised using these agents in lactating women to avoid adverse effects in the newborn ( 99). Sedation and the side effects associated with first-generation agents have been noted to occur, but to no greater extent than with placebo ( 10,14,101). Astemizole, like cyproheptadine, was associated with increased appetite and weight gain ( 10). Loratadine and fexofenadine have similar side effect profiles and have not been found to cause cardiotoxicity ( 3). Cetirizine is considered a low sedating antihistamine but is generally well tolerated by most patients. This phenomenon has been speculated to occur because of autoinduction of hepatic metabolism, resulting in an accelerated clearance rate of the antihistamine ( 103). Short-term studies evaluating tolerance to second-generation agents have found no change in their therapeutic efficacy after 6 to 8 weeks of regular use ( 108,109). Studies up to 12 weeks found no evidence that second-generation agents cause autoinduction of hepatic metabolism leading to rapid excretion rates and drug tolerance ( 42). The clinical efficacy of these agents in the skin and treatment of allergic rhinitis does not decrease with chronic use. The decongestants used in most preparations today predominantly include phenylpropanolamine hydrochloride, phenylephrine hydrochloride, and pseudoephedrine hydrochloride. These agents have saturated benzene rings without 3- or 4-hydroxyl groups, which is the reason for their weak a-adrenergic effect, improved oral absorption, and duration of action. The early agents, which were developed for their gastric acid inhibitory properties, were either not strong enough for clinical use or hazardous because of serious associated side effects (e. Cimetidine (Tagamet) was introduced to the United States in 1982 and has been proved safe and effective in the treatment of peptic ulcer disease (15). For example, ranitidine (Zantac) has a furan ring, whereas famotidine (Pepcid) and nizatidine (Axid) are composed of thiozole rings ( 15). H2 antagonists act primarily by competitive inhibition of the H 2 receptors, with the exception of famotidine, which works noncompetitively (15). The four available H2 antagonists all have potent H2 antagonistic properties, varying mainly in their pharmacokinetics, and adverse effects such as drug interactions. Numerous studies have been undertaken to examine the clinical utility of H 2 antagonists in allergic and immunologic diseases. Generally, H2 antagonists have limited or no utility in treating allergen-induced and histamine-mediated diseases in humans ( 118,119,120 and 121). One notable exception to this rule may be their use in combination with H 1 antagonists in the treatment of chronic idiopathic urticaria ( 122). The studies evaluating the clinical efficacy of H 2 antagonists in allergic and immunologic disorders are extensively reviewed elsewhere ( 3,117). These actions by histamine could not be suppressed by H 1 or H2 antagonists, leading researchers to postulate the existence of a third class of histamine receptors. They both have demonstrated H 3 receptor selectivity but remain strictly for experimental use (9). Chemical modifications of these early agents have yielded the second-generation antihistamines, which are of equal antagonistic efficacy but have fewer side effects because of their lipophobic structures. Newer nonsedating antihistamines, which are metabolites or isomers of existing agents, are now under development. H 2 receptor antagonists have been found extremely useful in the treatment of peptic ulcer disease. However, they have been disappointing in the treatment of allergic and immunologic disorders in humans. Newer selective nonsedating H1 antagonists and dual-action antihistamines, because of their lower side-effect profiles, have provided therapeutic advantages over first-generation agents for long-term management of allergic rhinitis.
10 of 10 - Review by M. Narkam
Votes: 126 votes
Total customer reviews: 126